The stress of spaceflight gives viruses a holiday from immune surveillance, putting future deep-space missions in jeopardy
Herpes viruses reactivate in more than half of crew aboard Space Shuttle and International Space Station missions, according to NASA research published in Frontiers in Microbiology. While only a small proportion develop symptoms, virus reactivation rates increase with spaceflight duration and could present a significant health risk on missions to Mars and beyond.
NASA’s rapid viral detection systems and ongoing treatment research are beginning to safeguard astronauts – and immunocompromised patients on Earth, too.
Herpes viruses reactivate in immunocompromised astronauts
“NASA astronauts endure weeks or even months exposed to microgravity and cosmic radiation – not to mention the extreme G forces of take-off and re-entry,” says senior author Dr. Satish K. Mehta of KBR Wyle at the Johnson Space Center. “This physical challenge is compounded by more familiar stressors like social separation, confinement and an altered sleep-wake cycle.”
To study the physiological impact of spaceflight, Mehta and colleagues analyze saliva, blood and urine samples collected from astronauts before, during and after spaceflight.
“During spaceflight there is a rise in secretion of stress hormones like cortisol and adrenaline, which are known to suppress the immune system. In keeping with this, we find that astronaut’s immune cells – particularly those that normally suppress and eliminate viruses – become less effective during spaceflight and sometimes for up to 60 days after.”
In the midst of this stress-induced amnesty on viral killing, dormant viruses reactivate and resurface.
“To date, 47 out of 89 (53%) astronauts on short space shuttle flights, and 14 out of 23 (61%) on longer ISS missions shed herpes viruses in their saliva or urine samples,” reports Mehta. “These frequencies – as well as the quantity – of viral shedding are markedly higher than in samples from before or after flight, or from matched healthy controls.”
Overall, four of the eight known human herpes viruses were detected. These include the varieties responsible for oral and genital herpes (HSV), chickenpox and shingles (VZV) – which remain lifelong in our nerve cells – as well as CMV and EBV, which take permanent but uneventful residence in our immune cells during childhood. CMV and EBV, are two viruses associated with causing different strains of mononucleosis or the “kissing disease”.
Deep-space exploration could depend on effective prevention and treatment
So far, this viral shedding is typically asymptomatic.
“Only six astronauts developed any symptoms due to viral reactivation,” says Mehta. “All were minor.”
However, continued virus shedding post flight could endanger immunocompromised or uninfected contacts on Earth, like newborns.
“Infectious VZV and CMV were shed in body fluids up to 30 days following return from the International Space Station.”
What’s more, as we prepare for human deep-space missions beyond the moon and Mars, the risk that herpes virus reactivation poses to astronauts and their contacts could become more crucial.
“The magnitude, frequency and duration of viral shedding all increase with length of spaceflight.”
Developing countermeasures to viral reactivation is essential to the success of these deep-space missions, argues Mehta.
“The ideal countermeasure is vaccination for astronauts – but this is so far available only against VZV.”
“Trials of other herpes virus vaccines show little promise, so our present focus is on developing targeted treatment regimens for individuals suffering the consequences of viral reactivation.
“This research has tremendous clinical relevance for patients on Earth too. Already, our spaceflight-developed technologies for rapid viral detection in saliva have been employed in clinics and hospitals around the world.”
The Latest on: Virus reactivation
via Google News
The Latest on: Virus reactivation
- Discovery reveals mechanism that turns herpes virus on and offon November 14, 2019 at 1:37 pm
Treatment of the virus is difficult, because it hides out in nerve cells and emerges months or years later to reactivate the infection. In Schang's group, Mi Yao Hu and Esteban Flores Cortes ...
- Few patients starting biologics, DMARDs screened for HBV, HCVon November 13, 2019 at 2:35 am
despite their potential increased risk for viral hepatitis reactivation, according to data presented at the 2019 ACR/ARP Annual Meeting. To evaluate pretreatment screening for hepatitis B and C virus ...
- Reassurance on Live-Virus Shingles Vax With Anti-TNFson November 11, 2019 at 3:24 pm
Patients with autoimmune diseases such as rheumatoid arthritis (RA) are known to be at increased risk for zoster virus reactivation, and certain of the treatments they frequently take, such as ...
- Live zoster vaccine safe, effective in patients taking TNF inhibitorson November 11, 2019 at 6:51 am
So, it would be really important, if you could, to lower the risk of shingles and reactivation of herpes zoster virus.” In 2006, a zoster vaccine live (Zostavax, Merck) was approved; however, ...
- Genes from ‘fossil’ virus in human DNA found to be activeon November 11, 2019 at 5:06 am
“There have been some reports that the virus, called human herpesvirus-6, can reactivate, but if it does, it’s rare,” said Dr. Alex Greninger, UW assistant professor of laboratory medicine. “What we ...
- Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting® 2019on November 8, 2019 at 4:12 pm
Test all patients for evidence of current or prior hepatitis B virus (HBV) infection before initiating treatment with EPCLUSA. HBV reactivation has been reported in HCV/HBV coinfected patients who ...
- Predicting the response of HIV-infected individuals to checkpoint inhibitor immunotherapyon November 7, 2019 at 9:49 am
More than thirty years after the identification of the Human Immunodeficiency Virus (HIV), this persistent infection is managed with multiple ... There is a type of immunotherapy known as checkpoint ...
- A pain like no otheron November 5, 2019 at 3:30 pm
The first one occurred when she was in her 40s when the varicella-zoster virus that had produced a childhood outbreak of chickenpox and then hid out in the cells of her nervous system for decades was ...
- Inday Neri wants HIV/Aids council reactivatedon November 4, 2019 at 4:48 pm
MANDAUE City Councilor Nerissa “Inday Neri” Soon-Ruiz wants to reactivate the council that deals with human immunodeficiency virus (HIV), which causes Acquired Immunodeficiency Syndrome (Aids). The ...
- Varicella-Zoster Virus Reactivation Is an Important Cause of Acute Peripheral Facial Paralysis in Childrenon October 31, 2019 at 5:00 pm
Background: Reactivation of herpes simplex virus type 1 is thought to be a major cause ... Our data indicate that VZV reactivation is an important cause of acute peripheral facial paralysis in ...
via Bing News